Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-02-16
BASIBioanalytical Systems IncDowning Philip ASVP, Preclinical Srvcs.P - Purchase$1.46+5,00015,765+46%+$7,300
2018-02-16
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$109.07-3,63911,671-24%-$396,899
A
2017-08-14
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$97.86-1,30315,310-8%-$127,508
2018-02-15
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$107.50-46343,1230%-$4,945
D
2018-02-15
NRCIANational Research CorpHays Michael D.CEOS - Sale+OE$19.31-5,261,410139,182-97%-$101,597,827
2018-02-15
NRCIANational Research CorpAmandla Mk Trust10%P - Purchase$19.31+5,494,4407,378,645+292%+$106,097,636
D
2018-02-15
CRLCharles River Laboratories International IncChubb Stephen DDirS - Sale+OE$108.69-2,87233,589-8%-$312,172
D
2018-02-13
PIRSPieris Pharmaceuticals, Inc.Orbimed Advisors LLC10%S - Sale+OE$8.98-7,89749,270-14%-$70,915
D
2018-02-09
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$45.72-101,488920,241-10%-$4,640,272
E
2017-12-19
HPPIHedgepath Pharmaceuticals, Inc.Cross StefanDirP - Purchase$0.27+600,0000-100%+$162,660
E
2017-12-19
HPPIHedgepath Pharmaceuticals, Inc.Mayne Pharma Ventures Pty Ltd10%P - Purchase$0.27+600,000198,106,1320%+$162,660
DM
2018-02-06
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$6.85-662,9127,088,903-9%-$4,542,234
D
2018-02-05
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$8.00-70,7217,751,815-1%-$566,037
DM
2018-01-29
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%S - Sale+OE$7.64-310,0007,822,536-4%-$2,368,864
D
2018-01-25
NRCIANational Research CorpHays Michael D.CEO, 10%S - Sale+OE$39.03-1,602,3995,400,592-23%-$62,541,633
M
2018-01-23
SRNESorrento Therapeutics, Inc.Asia Pacific Medtech (Bvi) Ltd10%S - Sale$7.56-684,2888,617,513-7%-$5,175,690
D
2018-01-23
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$50.49-110,439920,241-11%-$5,575,961
2018-01-22
SYNHSyneos Health, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale$41.00-1,47053,634-3%-$60,270
2018-01-19
XONIntrexon CorpKirk Randal JCEO, 10%P - Purchase$12.50+1,000,00058,928,289+2%+$12,500,000
D
2018-01-21
SRNESorrento Therapeutics, Inc.Ji HenrySee RemarksP - Purchase$0.00+1,801,8014,159,603+76%+$0
D
2018-01-17
AQBAquabounty Technologies, Inc.Kirk Randal J10%P - Purchase$3.25+1,538,4617,538,292+26%+$4,999,998
D
2018-01-17
IQVIqvia Holdings Inc.Erlinger III James HSee RemarksS - Sale+OE$99.97-10,00013,494-43%-$999,700
D
2018-01-16
PRAHPra Health Sciences, Inc.Baddour LindaEVP, CFOS - Sale+OE$90.27-67,0000-100%-$6,048,199
D
2018-01-12
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$52.80-125,402920,231-12%-$6,620,593
DM
2018-01-08
EXELExelixis, Inc.Garber Alan MDirS - Sale+OE$30.30-15,00061,329-20%-$454,515
D
2018-01-05
INCYIncyte CorpGryska David WEVP, CFOS - Sale+OE$98.87-6,76013,992-33%-$668,361
D
2018-01-03
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$52.54-1,66543,943-4%-$87,474
2018-01-03
PIRSPieris Pharmaceuticals, Inc.Orbimed Advisors LLC10%S - Sale$7.35-1,709,62049,270-97%-$12,565,707
2018-01-02
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$110.31-3,465305,606-1%-$382,229
2018-01-02
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$110.16-9,246298,731-3%-$1,018,558
2018-01-02
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$109.78-7,322307,977-2%-$803,823
2018-01-02
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$109.44-4,967315,299-2%-$543,590
D
2018-01-02
INCYIncyte CorpIyengar Vijay KEVP GPS, BD, LicensingS - Sale+OE$97.26-5,0008,676-37%-$486,300
2018-01-02
CRLCharles River Laboratories International IncBertolini Robert JDirS - Sale$110.22-3,60922,586-14%-$397,785
D
2018-01-02
CRLCharles River Laboratories International IncBertolini Robert JDirS - Sale+OE$109.59-4,13126,195-14%-$452,717
2018-01-02
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$110.38-3,10011,671-21%-$342,191
2018-01-02
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$110.01-8,23114,771-36%-$905,497
D
2018-01-02
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$109.53-5,48623,002-19%-$600,891
D
2017-12-28
PRAHPra Health Sciences, Inc.Dockhorn David WEVP, CCOS - Sale+OE$90.83-72,8500-100%-$6,617,245
D
2017-12-22
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$52.58-123,512920,231-12%-$6,494,790
D
2017-12-20
IQVIqvia Holdings Inc.Erlinger III James HSee RemarksS - Sale+OE$101.21-10,00016,232-38%-$1,012,100
D
2017-12-18
PIRSPieris Pharmaceuticals, Inc.Orbimed Advisors LLC10%S - Sale+OE$5.70-147,63565,398-69%-$841,520
2017-12-18
TENXTenax Therapeutics, Inc.Blanck Ronald RDirP - Purchase$0.45+12,95020,099+181%+$5,887
D
2017-12-11
FCSCFibrocell Science, Inc.Kirk Randal J10%P - Purchase$0.77+2,727,2738,267,413+49%+$2,100,000
D
2017-12-06
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$53.45-121,849920,231-12%-$6,513,179
D
2017-12-06
CRLCharles River Laboratories International IncReese C RichardDirS - Sale+OE$102.40-10,22756,457-15%-$1,047,245
2017-12-05
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$30.16-4,600,00016,399,997-22%-$138,741,980
D
2017-12-01
IQVIqvia Holdings Inc.Bousbib AriSee RemarksS - Sale+OE$101.79-46,0801,534,061-3%-$4,690,483
2017-12-01
INCYIncyte CorpHuber Reid MEVP, Chief Scientific OfficerS - Sale$98.01-69638,205-2%-$68,215
2017-11-30
IQVIqvia Holdings Inc.Danhakl John GDirS - Sale$102.00-800,2763,376,167-19%-$81,628,152
2017-11-30
IQVIqvia Holdings Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$102.00-5,419,97122,865,529-19%-$552,837,042
2017-12-01
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$58.27-45,770205,963-18%-$2,667,204
2017-11-30
IQVIqvia Holdings Inc.Connaughton JohnDirS - Sale$102.00-1,163,1915,402,050-18%-$118,645,482
2017-11-30
IQVIqvia Holdings Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$102.00-7,497,80710,550,400-42%-$764,776,314
2017-08-24
LUNALuna Innovations IncGraeff Scott ACEOP - Purchase$1.43+10,000309,427+3%+$14,300
2017-08-24
LUNALuna Innovations IncMessick Dale ECFOP - Purchase$1.40+10,000204,270+5%+$14,000
D
2017-11-21
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$59.50-134,057920,231-13%-$7,976,660
2017-11-16
INCYIncyte CorpFriedman Paul ADirS - Sale$105.24-28,507269,011-10%-$3,000,077
2017-11-14
TENXTenax Therapeutics, Inc.Blanck Ronald RDirS - Sale$0.39-12,9507,149-64%-$5,051
D
2017-11-15
IQVIqvia Holdings Inc.Erlinger III James HSee RemarksS - Sale+OE$102.17-10,00017,340-37%-$1,021,700
2017-11-16
PRAHPra Health Sciences, Inc.Young Matthew P.DirS - Sale$79.90-5,1152,810-65%-$408,689
2017-11-13
XONIntrexon CorpLast Andrew J.COOP - Purchase$12.10+2,0004,000+100%+$24,200
D
2017-11-09
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$59.14-137,805920,231-13%-$8,149,669
D
2017-11-06
QIqvia Holdings Inc.Greenberg Jack MDirS - Sale+OE$108.07-33,40030,316-52%-$3,609,388
2017-11-01
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$36.50-9,0005,751,5220%-$328,500
D
2017-11-01
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$108.14-46,0801,534,061-3%-$4,983,091
2017-11-01
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$53.60-45,775251,733-15%-$2,453,768
2017-11-02
INCYIncyte CorpGryska David WEVP, CFOS - Sale$105.63-3,91513,992-22%-$413,541
M
2017-10-26
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-18,1955,760,5220%-$691,442
2017-10-25
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.39+3751,012,2500%+$1,646
M
2017-10-23
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-2,3945,778,7170%-$90,972
2017-10-24
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.92+3751,011,8750%+$1,845
M
2017-10-19
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$37.01-110,1445,781,111-2%-$4,076,520
D
2017-10-18
QQuintiles Ims Holdings, Inc.Erlinger III James HSee RemarksS - Sale+OE$100.51-10,00017,340-37%-$1,005,100
2017-10-19
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.49+3751,011,5000%+$1,684
2017-10-17
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.27+3751,011,1250%+$1,601
2017-10-13
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.22+7501,010,7500%+$3,165
D
2017-10-05
CRLCharles River Laboratories International IncJohst David PCorporate EVPS - Sale+OE$110.00-24,759181,255-12%-$2,723,490
D
2017-10-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$110.00-6,16563,566-9%-$678,150
2017-10-05
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.30+3751,010,0000%+$1,613
D
2017-10-02
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$47.16-81,025297,508-21%-$3,820,734
D
2017-10-02
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$47.16-29,11539,239-43%-$1,373,115
D
2017-10-02
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$94.91-46,0801,534,061-3%-$4,373,453
2017-10-02
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.20+3751,009,6250%+$1,575
D
2017-09-27
QQuintiles Ims Holdings, Inc.Erlinger III James HSee RemarksS - Sale+OE$94.52-10,00017,340-37%-$945,200
2017-09-28
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.21+3751,009,2500%+$1,579
DM
2017-09-27
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale+OE$24.28-27,302268,260-9%-$663,018
DM
2017-09-26
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.79-100,000197,191-34%-$2,378,667
2017-09-26
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.88+3751,008,8750%+$1,455
2017-09-22
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale$25.40-10,0001,034,314-1%-$254,000
2017-09-19
QQuintiles Ims Holdings, Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$94.87-6,748,02613,049,669-34%-$640,185,227
2017-09-19
QQuintiles Ims Holdings, Inc.Danhakl John GDirS - Sale$94.87-720,2484,176,443-15%-$68,329,928
2017-09-19
QQuintiles Ims Holdings, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$94.87-4,877,97428,285,500-15%-$462,773,393
2017-09-19
QQuintiles Ims Holdings, Inc.Connaughton JohnDirS - Sale$94.87-1,030,4296,682,534-13%-$97,756,799
M
2017-09-18
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-20
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.23+3751,008,5000%+$1,586
2017-09-18
INCYIncyte CorpHoppenot HerveCOB , CEOS - Sale$119.45-70,502299,004-19%-$8,421,464
2017-09-18
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale$54.55-4,68255,897-8%-$255,427
2017-09-18
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale$54.48-9,70378,593-11%-$528,600
2017-09-18
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale$54.60-2,34899,453-2%-$128,201

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top